Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.63 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.58 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.58 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 4/20 | 0.47 |
| ▸ | KDM5A | P29375 | 3/20 | 0.47 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15236225 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL4687503 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL4952272 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8980674 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8980557 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8980621 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL20345235 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8980627 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL8980618 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 | |
| SCHEMBL12462786 | 1.00 | DNM1 (0.63) | DNM1S1PR2S1PR1S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362283-A1 | NISIN-BASED COMPOUNDS AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS | UNIVERSITEIT UTRECHT HOLDING B.V. (NL) | 2017-12-21 | — | — | US | disclosed |
| EP-3060634-A1 | USE OF AN ALKOXYLATED POLYTETRAHYDROFURAN AS AN ADDITIVE IN A FUEL | BASF SE (DE) | 2016-08-31 | — | — | EP | disclosed |
| EP-3060637-A2 | USE OF A POLYALKYLENE GLYCOL TO REDUCE FUEL CONSUMPTION | BASF SE (DE) | 2016-08-31 | — | — | EP | disclosed |
| EP-3060636-A2 | USE OF A COMPLEX ESTER TO REDUCE FUEL CONSUMPTION | BASF SE (DE) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015058992-A1 | USE OF AN ALKOXYLATED POLYTETRAHYDROFURAN AS AN ADDITIVE IN A FUEL | BASF SE (DE) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015059063-A2 | USE OF A COMPLEX ESTER TO REDUCE FUEL CONSUMPTION | BASF SE (DE) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015058993-A2 | USE OF A POLYALKYLENE GLYCOL TO REDUCE FUEL CONSUMPTION | BASF SE (DE) | 2015-04-30 | — | — | WO | disclosed |
| WO-2014023853-A2 | TERTIARY AMINES FOR REDUCING INJECTOR NOZZLE FOULING AND MODIFYING FRICTION IN DIRECT INJECTION SPARK IGNITION ENGINES | BASF SE (DE) | 2014-02-13 | — | — | WO | disclosed |
| US-5536425-A | DURABILITY | SONY CORPORATION (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5453539-A | Durability | SONY CORPORATION (JP) | 1995-09-26 | — | — | US | disclosed |
| EP-0519406-A2 | Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same | SONY CORPORATION (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-4138437-A | REACTING ALCOHOL OR ALDEHYDE WITH DIMETHYLAMINE IN THE PRESENCE OF COPPER-CHROMIUM OXIDE CATALYST AND HYDROGEN | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362283-A1 | NISIN-BASED COMPOUNDS AND USE THEREOF IN THE TREATMENT OF BACTERIAL INFECTIONS | NISCH, VIP, NGLY1 | DNM1 2153/4885S1PR2 2614/4885S1PR1 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.